Daly Timothy 4
4 · Ovid Therapeutics Inc. · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Daly Timothy
VP, Finance & Corp. Controller
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-02-24+50,000→ 50,000 totalExercise: $1.89Exp: 2029-02-23→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.